Bis(7)-tacrine ameliorates cognitive impairment caused by cerebral hypoperfusion in rats
The effects ofbis(7)-tacrine, a novel acetylcholinesterase inhibitor, on cognitive impairment and neuronal degeneration induced by permanent ligation of bilateral common carotid arteries (2VO) were investigated using the Morris water maze in rats. Once daily oral administration ofbis(7)-tacrine (0.025, 0.05 and 0.1 mg·kg−1) was started 14 days after 2VO operation. Over a three-week treatmentbis(7)-tacrine effectively reversed 2VO-induced spatial memory deficits in a dose-dependent fashion. Furthermore, histological observation showedbis(7)-tacrine decreased the neuropathological changes in the 2VO rats brain. These results suggest thatbis(7)-tacrine has therapeutic potential for the treatment of dementia caused by chronic cerebral hypoperfusion.
Key wordsbis(7)-tacrine acetylcholinesterase inhibitor permanent bilateral occlusion of common carotid arteries vascular dementia
CLC numberR 965 R 749.16
Unable to display preview. Download preview PDF.
- Wang H, Carlier P R, Ho W L,et al. Attenuation of Scopolamine-Induced Deficits in Navigational Memory Performance in Rats byBis(7)-Tacrine, a Novel Dimeric AChE Inhibitor.Acta Pharmacol Sin, 1999,20(3): 211–217.Google Scholar
- Roman G C, Tatemichi T K, Erkinjuntti T,et al. Vascular Dementia: Diagnostic Criteria for Research Studies.Neurology, 1993,43(2):250–260.Google Scholar
- de la Torre J C, Fortin T, Park G Aet al. Can Disturbed Brain Microcirculation Cause Alzheimer's Disease?Neurological Res, 1993,15(3):146–153.Google Scholar
- Vesce S, Bezzi P and Volterra A. The Highly Integrated Dialogue between Neurons and Astrocytes in Brain Function.Sci Prog, 1999,82(pt3):251–270.Google Scholar